期刊文献+

甲型乙型肝炎联合疫苗诱导小鼠免疫应答特点的研究 被引量:2

A Study on the Immune Response Induced by Hepatitis A and B Combined Vaccine in Mice
原文传递
导出
摘要 目的比较甲型乙型肝炎联合疫苗(Hepatitis A and B Combined Vaccine,HepAB)与重组乙型肝炎(乙肝)疫苗(酿酒酵母)(Hepatitis B Vaccine Made by Recombinant Deoxyribonucleic Acid Techniques in SaccharomycesCerevisiae Yeast,HepB-SCY)、甲型肝炎(甲肝)灭活疫苗(Hepatitis A Virus Inactivated Vaccine,HepA-Ⅰ)诱导小鼠细胞免疫和体液免疫应答的特点。方法 4组无特定病原体的BALB/c小鼠(H-2d,6~8周龄,16~18克,雌性),分别皮下接种HepAB[含甲肝抗原150单位(Unit,U)、乙肝抗原3微克(μg)]、HepB-SCY(含乙肝抗原3μg)、HepA-Ⅰ(含甲肝抗原150U)及铝佐剂对照,于免疫后14d分离脾单个核细胞(Mononuclear Cell,MNC),应用酶联免疫斑点试验(Enzyme-linked Immunospot Assay,ELISPOT)测定MNC体外刺激后所产生的细胞因子干扰素(Interferon,IFN)-γ、白细胞介素(Interleukin,IL)-2斑点形成细胞数(Spots-forming Cell,SFC);同时应用酶联免疫吸附试验(Enzyme-linked Immunosorbent Assay,ELISA)检测免疫后脾MNC培养上清中诱导分泌抗原特异性IFN-γ细胞因子的含量;分别于免疫后14d、28d检测小鼠血清抗甲肝病毒抗体(Antibody to Hepatitis AVirus,Anti-HAV)IgG和抗乙肝病毒表面抗原抗体(Antibody to Hepatitis B Virus Surface Antigen,Anti-HBs)水平。结果应用ELISPOT法检测,HepAB免疫小鼠后诱导乙肝抗原特异性IL-2分泌水平(50%)高于HepB-SCY(20%),HepAB组诱导甲肝抗原特异性IFN-γ阳转率(70%)高于HepA-Ⅰ组(30%),且HepAB诱导乙肝抗原特异性IFN-γ分泌水平(80%)均显著高于HepB-SCY组(30%)(P=0.03489)。应用ELISA法检测HepAB免疫后脾MNC培养诱导分泌甲肝抗原特异性IFN-γ阳转率(80%),也显著高于HepA-Ⅰ组(20%)(P=0.01151)。HepAB组于免疫14d、28d诱导的Anti-HBs抗体滴度分别为93.6毫国际单位/毫升(mIU/ml)和476.8 mIU/ml,均高于HepB-SCY组的26.5 mIU/ml和237.8 mIU/ml。结论两种细胞免疫评价方法结果均表明,HepAB诱导抗原特异性细胞免疫应答反应优于HepB-SCY、HepA-Ⅰ;HepAB与HepB-SCY相比较,在诱导Anti-HBs水平方面也同样具有优势。 Objective To compare the cellular and humoral immune responses to the hepatitis A and B combined vaccine(HepAB)with hepatitis B vaccine made by recombinant deoxyribonucleic acid techniques in saccharomyces cerevisiae yeast(HepB-SCY)and hepatitis A virus(HAV)inactivated vaccine(HepA-I)in immunized mice.Methods Levels of interferon(IFN)-γ and interleukin(IL)-2 secreted by splenic mononuclear cells(MNC)of the vaccinated mice were detected by enzyme-linked immunospot method(ELISPOT)after in vitro stimulation with hepatitis B virus surface antigen(HBsAg)major histocompatibility complex(MHC)class I peptide S28-39,HBsAg or purified HAV,respectively.The cytokine concentration of IFN-γ secreted by MNCs of mice was detected by enzyme-linked immunosorbent assay(ELISA)method after stimulation with HBsAg or purified HAV.Levels of antibody to HBsAg(anti-HBs)and antibody to HAV(anti-HAV)were measured by the Abbott ARCHITECT Diagnostic kit.Results The HBsAg specific SFCs of IFN-γ and IL-2 secreted by MNCs of HepAB were higher than those of the HepB-SCY after in vitro stimulation with HBsAg MHC class I peptide S28-39 or HBsAg.The SFCs of IFN-γ,secreted by MNCs of HepAB were higher than those of HepA-I after in vitro stimulation with purified HAV.The cytokine concentration of IFN-γ,secreted by MNCs of HepAB was also higher than that of monovalent vaccine after stimulation with HBsAg or purified HAV.At different time,level of anti-HBs of HepAB were higher than that of HepB-SCY(93.6mIU/ml,476.8mIU/ml;26.5mIU/ml,237.8 mIU/ml).Conclusion Results of two kinds of cellular immune assays showed that responses to HepAB were higher than those to monovalent vaccines.The combined vaccine also induces higher level of anti-HBs.
出处 《中国疫苗和免疫》 CAS 2011年第5期387-390,403,共5页 Chinese Journal of Vaccines and Immunization
基金 国家科学技术重大专项艾滋病和病毒性肝炎等重大传染病防治专项"乙型肝炎疫苗质量控制及评价研究"课题(编号:2009ZX10004-802)
关键词 甲型肝炎 乙型肝炎 疫苗 细胞免疫 酶联免疫斑点法 抗乙型肝炎病毒表面抗原抗体 抗甲型肝炎病毒抗体IgG Hepatitis A Hepatitis B Vaccine Cellular immunology Enzyme-linked immunospot assay Antibody to hepatitis B virus surface antigen Antibody to hepatitis A virus IgG
  • 相关文献

参考文献18

  • 1戴志澄,祁国明.中国病毒性肝炎血清流行病学调查(上卷)(1992-1995年)[M].北京:科学技术文献出版社,1997:39-59.
  • 2冯子健,尹卫东.甲乙型肝炎联合疫苗临床研究综述[J].中国计划免疫,2005,11(4):322-326. 被引量:6
  • 3李军宏,朱徐,等.甲、乙型肝炎联合疫苗的应用研究进展[J].中国计划免疫,2002,8(5):291-294. 被引量:4
  • 4巩志立.甲乙型肝炎联合疫苗和多价联合疫苗研究概况[J].国外医学(预防.诊断.治疗用生物制品分册),1999,22(6):241-243. 被引量:3
  • 5IwarsonS,李雪翔.研制甲型和乙型肝炎疫苗的新途径[J].国外医学(预防.诊断.治疗用生物制品分册),1996,19(4):145-148. 被引量:1
  • 6Kallinowski B, Knoll A, Lindner E, et al. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course? [J]. Vaccine, 2000, 19 (1): 16-22.
  • 7]Knoll A, Hottentrager B, Kainz J, et al. Immunogenicity of a combined hepatitis A and hepatitis B vaccine in healthy young adults [J]. Vaccine, 2000, 18 (19): 2029-2032.
  • 8Joines RW, Blatter M, Abraham B, et al. A prospective, randomized, comparative US trial of a combination hepatitis A and hepatitis B vaccine ( TwinrixR ) with corresponding monovalent vaccines (havrix and Engerix-B ) in adults [ J]. Vaccine, 2001, 19 ( 32 ): 4710-4719.
  • 9Van Damme P, Lerouxs-Roels G, Law B, et al. Long-termpersistence of antibodies induced by vaccination and safety follow- up, with the first eombined vaccine against hepatitis A and B in children and adults [ J] .J Med Virol, 2001, 65 ( 1 ): 6-13.
  • 10Ambrosch F, Wiedermann G, Andre FE, et aL Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine [ J ]. J Med Virol, 1994, 44 (4) . 452-456.

二级参考文献74

  • 1万宗举,张华远,梁争论,李荣成,赵玉良,毕胜利.倍尔来福^(TM)甲乙型肝炎联合疫苗在成人中应用的安全性和免疫原性研究[J].中国计划免疫,2004,10(3):129-132. 被引量:20
  • 2贾秀岩,刘丹,吕作芝,张萍,张小梅,高学谦,张元强.孩尔来福甲型肝炎灭活疫苗在儿童中应用的安全性和免疫原性观察[J].中国计划免疫,2004,10(4):213-214. 被引量:7
  • 3巩志立,李虹,谢东生,唐巧英,邓金娣,王鸿燕,阚毓筠,韩洪林,白荣英,周双福,杨光林.乙肝-白-百-破四联疫苗的实验研究[J].中国生物制品学杂志,1994,7(2):83-84. 被引量:7
  • 4[3]Knoll A,Hottentrager B, Kainz J, et al.Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults[J].Vaccine,2000,18(19):2029-2032.
  • 5[4]Lee S D,Chan C Y,Yu M I, et al.A two dose combined hepatiitis A and B vaccine in Chinese youngsters[J].J Med Virol,1999,59(1):1-4.
  • 6[5]Bruguera M,Bayas J M, Vilella A, et al.Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults[J].Vaccine,1996,14(15):1407-1411.
  • 7[6]Thoelen S,Van Damme P, Leentvaar-Kuypers A, et al. The first combined vaccine against hepatitis A and B:an overview[J].Vaccine,1999,17(13-14):1657-1662.
  • 8[7]Abraham B,Baine Y, De-Clercq N, et al.Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine[J].Antiviral Res,2002,53(1):63-73.
  • 9[8]Van Damme P,Leroux-Roels G, Law B, et al.Long-term persistence of antibodies induced by vaccination and safety follow-up,with the first combined vaccine against hepatitis A and B in children and adults[J].J Med Virol,2001,65(1):6-13.
  • 10[9]Joines R W,Blatter M, Abraham B, et al.A prospective,randomized,comparative US trial of a combination hepatitis A and B vaccine(TwinrixD○R)with corresponding monovalent vaccines(Havrix and Engerix-B)in adults[J].Vaccine,2001,19(32):4710-4719.

共引文献30

同被引文献40

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部